IDH1/IDH2 mutations predict survival in glioma and AML

被引：0
|
作者：
Hegi, M. [1 ]
机构：
[1] CHUV, Lausanne, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72597-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [21] A new IDH1/2 PCR assay for one-step detection of 12 IDH1 and IDH2 mutations in glioma
    Girardi, H.
    Monville, F.
    Poggionovo, C.
    Catteau, A.
    Giry, M.
    Voos, J.
    Jenkins, R. B.
    Mokhtari, K.
    Peyro-Saint-Paul, H.
    Giannini, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S213 - S213
  • [22] A NEW IDH1/2 PCR ASSAY FOR ONE-STEP DETECTION OF 12 IDH1 AND IDH2 MUTATIONS IN GLIOMA
    Girardi, Helene
    Monville, Florence
    Carpentier, Sabrina
    Giry, Marine
    Voss, Jesse
    Jenkins, Robert
    Boisselier, Blandine
    Frayssinet, Veronique
    Poggionovo, Cecile
    Catteau, Aurelie
    Mokhtari, Karima
    Sanson, Marc
    Peyro-Saint-Paul, Helene
    Giannini, Caterina
    NEURO-ONCOLOGY, 2013, 15 : 158 - 158
  • [23] AML patients with IDH1 or IDH2 mutations treated with hypomethylating agents: A case series
    Benton, Christopher Brent
    Ravandi, Farhad
    Andreeff, Michael
    Kantarjian, Hagop
    Konopleva, Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] The clinical use of IDH1 and IDH2 mutations in gliomas
    Picca, Alberto
    Berzero, Giulia
    Di Stefano, Anna Luisa
    Sanson, Marc
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (12) : 1041 - 1051
  • [25] IDH1 and IDH2 mutations in pediatric acute leukemia
    A K Andersson
    D W Miller
    J A Lynch
    A S Lemoff
    Z Cai
    S B Pounds
    I Radtke
    B Yan
    J D Schuetz
    J E Rubnitz
    R C Ribeiro
    S C Raimondi
    J Zhang
    C G Mullighan
    S A Shurtleff
    B A Schulman
    J R Downing
    Leukemia, 2011, 25 : 1570 - 1577
  • [26] IDH1 and IDH2 mutations in pediatric acute leukemia
    Andersson, A. K.
    Miller, D. W.
    Lynch, J. A.
    Lemoff, A. S.
    Cai, Z.
    Pounds, S. B.
    Radtke, I.
    Yan, B.
    Schuetz, J. D.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Raimondi, S. C.
    Zhang, J.
    Mullighan, C. G.
    Shurtleff, S. A.
    Schulman, B. A.
    Downing, J. R.
    LEUKEMIA, 2011, 25 (10) : 1570 - 1577
  • [27] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    LABORATORY INVESTIGATION, 2012, 92 : 184A - 184A
  • [28] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    MODERN PATHOLOGY, 2012, 25 : 184A - 184A
  • [29] Mutations of IDH1 and IDH2 are not frequent in Multiple Myeloma
    Langer, C.
    Ibanez, M.
    Liebisch, P.
    Zenz, T.
    Knop, S.
    Einsele, H.
    Paschka, P.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2011, 34 : 159 - 159
  • [30] IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
    Houillier, C.
    Wang, X.
    Kaloshi, G.
    Mokhtari, K.
    Guillevin, R.
    Laffaire, J.
    Paris, S.
    Boisselier, B.
    Idbaih, A.
    Laigle-Donadey, F.
    Hoang-Xuan, K.
    Sanson, M.
    Delattre, J. -Y.
    NEUROLOGY, 2010, 75 (17) : 1560 - 1566
12345